SUBSCRIBE
← All supplements

Supplement

Slippery Elm

A real throat coating, two centuries of use, and not one trial of the ingredient alone.

Slippery elm is the inner bark of Ulmus rubra, a North American tree. We grade Slippery Elm D+ on evidence and D for worth-it at about $10-18 per month.

D+

Evidence

D

Worth it

Typical cost: $10-18/month

What it does

Slippery elm is the inner bark of Ulmus rubra, a North American tree. Ground and mixed with water, it forms a thick mucilage gel that coats whatever it touches. It has been used since the 1800s for sore throats and digestive irritation, and it is promoted today, including by Barbara O'Neill, for reflux, gastritis, and gut healing.

What the research says

  • Coats and soothes a sore throat, as a demulcent; the mechanism is mechanical and real

    Evidence: emerging. Slippery elm bark is one of four demulcents named in the FDA's over-the-counter monograph for minor sore mouth and throat discomfort, as a lozenge. Demulcent-class studies show the coating itself produces genuine, brief pain relief. The one placebo-controlled trial in this space (Brinckmann 2003) tested a tea blend that was 8.5 percent slippery elm and beat placebo on throat pain; which ingredient did the work cannot be known from that design.

  • No trial has ever tested slippery elm on its own, for anything

    Evidence: weak. A PubMed census finds three clinical trials naming slippery elm, all testing blends of four to eight ingredients. The only placebo-controlled blend trial (an eight-herb formula, 22 women) found no benefit. Every gut claim (reflux, gastritis, IBS, ulcerative colitis) traces to combination pilots, open-label series, historical pharmacopeia listings, or lab studies of the mucilage. That is the whole file.

  • Gut-coating claims face a dilution problem the throat claims do not

    Evidence: weak. A lozenge bathes the throat in mucilage for minutes. A swallowed capsule's gel is diluted in stomach contents and acid, and what coating reaches the lower gut is thin and brief. The plausible use and the promoted uses are different uses.

This is what an evidence file looks like when it is nearly empty: three blend trials that cannot attribute their results, a regulatory listing for the lozenge form that certifies a coating action, and two centuries of traditional use. Traditional use is evidence that people kept using it, and for a benign mechanical demulcent aimed at a sore throat, that plus the monograph carries it above a flat D. For the gut conditions it is mostly sold for, there is no human evidence to grade, and the grade reflects the record as purchased, not the best-case use.

The week's longevity and biohacking news.

This grade for Slippery Elm rests on the record above. When a new result changes that record, the grade changes with it, and the Thursday email is where the change lands first: the week's longevity and biohacking news, in plain English, linked back to the reasoning on this page.

The week's longevity and biohacking news. Every story graded against the evidence. Free. Unsubscribe anytime.

Every grade follows a published rubric, and sponsors never change one. When the evidence moves a grade, Thursday is where you hear it first, before you renew a stack that stopped earning its cost.

Is it worth it?

D

Evidence (D+) sits far below the leaderboard floor, so the worth-it grade is capped at C+ however inexpensive it is; the derived value lands at D. About $14 a month in lozenge or powder form. Derived from the October 2026 worth-it model.

Typical cost

$10-18/month

Common form, not a brand recommendation

Dosage context established

Traditional preparations: 1 to 3 g of powdered inner bark stirred into water as a gruel, or lozenges (the monograph form is 10 to 15 percent elm bark in a solid lozenge, dissolved slowly, as often as every 2 hours). No dose has ever been established by a trial of the ingredient alone, for any purpose.

Worth-it leaderboard

Slippery Elm sits outside the worth-it top 20.

Slippery Elm sits outside the current top 20 on the gated leaderboard. The leaders below clear an evidence floor of B- before price counts at all, so cheap alone never earns a rank.

  1. 1ACreatine evidence A-~$5-10/mo
  2. 2ACaffeine evidence B+~$5-10/mo
  3. 3AVitamin D evidence B~$5-8/mo

See the full worth-it leaderboard →

When the evidence moves a grade, this ranking moves with it. Thursday is where you hear it first.

Safety notes

Genuinely benign at usual doses, with one practical interaction: the mucilage can slow the absorption of oral medications, so take medicines at least an hour before or two hours after it. Historical pregnancy cautions exist around whole-bark preparations; powdered inner bark at normal doses has no documented harm signal, and caution in pregnancy remains the standard advice for an untested ingredient. A sourcing note worth printing: slippery elm is wild-harvested from a tree under pressure from disease and overharvest, and conservation groups list it as at-risk, which is a reason to buy from cultivated sources.

Longevity Lab Report

Slippery Elm news. Graded when it happens.

The grade on this page stays free. The email carries the news on slippery elm: expert moves, dose changes, and what is working, in plain English every Thursday.

Changelog

Last updated 2026-10-23

  • 2026-10-23|Graded from the trial census (zero trials of slippery elm alone), the FDA demulcent monograph listing, and the one placebo-controlled blend trial for sore throat. The record credits the mechanical coating effect where it genuinely operates, the throat, and states the absence of evidence plainly for the gut uses it is mostly sold for.
  • 2026-10-23|Not listed under any goal: the library's ten goals include no throat or digestion category, and this record's graded findings do not map onto the others.